Clinical Trials Logo

Clinical Trial Summary

Anastomotic leakage is a serious complication after LAR with high morbidity and mortality rates. Early diagnosis and treatment is mandatory. The primary aim of the present study is to investigate the clinical use of peritoneal microdialysis and whether is able to detect anastomotic leakage prior to clinical symptoms develops.


Clinical Trial Description

Patients undergoing LAR for recto-sigmoid cancer is subjected to peritoneal microdialyses during the postoperative period until discharge. Subcutaneous microdialysis serve as control. Samples are collected every 4-hour. Samples will be analyzed continuously but the results will not be included in the clinical evaluation of the patient.

Patients undergoing abdomino-perineal rectal resection will serve as a control group.

A total of 50 patients will be included in this pilot study. The results of the peritoneal microdialyses will be compared with the clinical course in each patient. The results form the uncomplicated courses will be used to define the normal variations in peritoneal microdialysis. This will be compared to results from patients with various complications.

The study is approved by the local scientific ethical committee No. ------ ;


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00271986
Study type Observational
Source Odense University Hospital
Contact
Status Completed
Phase N/A
Start date January 2006
Completion date January 2008

See also
  Status Clinical Trial Phase
Completed NCT04160650 - Educational Nursing Intervention Among Patients With Colorectal Cancer During Chemotherapy N/A
Recruiting NCT02948348 - Study to Nivolumab Following Preoperative Chemoradiotherapy Phase 1/Phase 2
Recruiting NCT01403883 - Psychological and Enterostomal Therapy Care N/A
Recruiting NCT05179824 - Tempus Priority Study: A Pan-tumor Observational Study
Completed NCT04716010 - Developing and Evaluating Product Messaging N/A
Completed NCT04319354 - Evaluation of cfDNA as a Marker of Response in Rectal Cancer N/A
Completed NCT02641691 - Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum Phase 2
Recruiting NCT03573791 - Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
Recruiting NCT04456283 - Survival of Patients With a Reduction in the Number of Lymph Nodes in Rectal Cancer After Neoadjuvant Chemoradiotherapy
Recruiting NCT05358704 - Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer Phase 2
Not yet recruiting NCT03910283 - Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer N/A
Recruiting NCT03896958 - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Recruiting NCT05887531 - Abdominopelvic Cancer Prehabilitation N/A
Completed NCT04880772 - Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery N/A
Recruiting NCT04095299 - Standard Dose Versus High Dose of Radiotherapy in Rectal Preservation With Chemo-radiotherapy in Rectal Cancer Patients Phase 2
Recruiting NCT06181201 - Association Between the Composition of the Intestinal Microbiota and Tumor Response in Locally Advanced Rectal Cancer
Not yet recruiting NCT03607643 - A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies Phase 1/Phase 2
Terminated NCT04812743 - Colorectal Health Research Champions N/A
Recruiting NCT03452774 - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting NCT05732389 - Immunotherapy in Patients With Early dMMR Rectal Cancer Phase 2